Overview

• Ten pediatric hospitals across five states will supervise the treatment.
• Eligible babies will receive increasing doses of peanut powder over two years.
• The program aims to reduce the risk of life-threatening allergic reactions.
• Initial trials have shown promise, but this is the first national rollout.
• Families are advised not to attempt the treatment without medical supervision.